Literature DB >> 7014105

Comparison of the antihypertensive activities of xipamide and chlorthalidone: a double-blind, randomized, crossover trial.

D Bonaduce, N Ferrara, M Petretta, V Canonico, E Romango, F Rengo.   

Abstract

The effectiveness of a new potent diuretic, xipamide, was evaluated in the treatment of patients with mild to moderate essential hypertension. The effects of daily doses of 40 mg xipamide were compared with those of 100 mg chlorthalidone with respect to systolic and diastolic blood pressure, using a double-blind crossover design. Patients received each drug for 6 weeks, the order of treatments being at random and the periods being separated by a 'washout' period of 7 days. The results showed that xipamide was as effective as chlorthalidone in controlling blood pressure, both in the upright and supine positions, and when administered after chlorthalidone produced a further reduction. No such further reduction occurred when chlorthalidone was given after xipamide. Serum electrolyte changes induced by the two diuretics were comparable. Both drugs were well tolerated and caused few side-effects.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7014105     DOI: 10.1185/03007998109114270

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  4 in total

Review 1.  Selective alpha 1-adrenoreceptor blockers in the treatment of hypertension: should we be using them more?

Authors:  M Ligueros; R Unwin; M Wilkins
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435

Review 2.  Blood pressure-lowering efficacy of loop diuretics for primary hypertension.

Authors:  Vijaya M Musini; Pouria Rezapour; James M Wright; Ken Bassett; Ciprian D Jauca
Journal:  Cochrane Database Syst Rev       Date:  2015-05-22

Review 3.  Xipamide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  B N Prichard; R N Brogden
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

4.  Xipamide: no advantage over bendrofluazide in hypertension.

Authors:  L E Ramsay; S Freestone
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.